News | August 01, 2023
Concord Biotech’s IPO to open on 4th August, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
CMOs showed an increasing reluctance to take on debt in 2022
Adding 20,000 liters of installed biologics drug substance manufacturing capacity
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
Subscribe To Our Newsletter & Stay Updated
